Plasma NFL levels further correlate with longitudinal measures of cognition and atrophy in AD and have been suggested as a tool for screening patients at risk of cognitive decline (78); however, NFL is not specific for AD, thus cannot help in the differential diagnosis with other neurodegenerative conditions. The gene discussed is NEFL; the disease is Atrophy.